Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis. 2009 Jun; 204(2):515-20.

View in: PubMed

subject areas

Aged
Blood Pressure
Cardiovascular Diseases
Cholesterol, HDL
Cholesterol, LDL
Female
Heptanoic Acids
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Ischemic Attack, Transient
Male
Middle Aged
Proportional Hazards Models
Pyrroles
Risk Assessment
Risk Factors
Secondary Prevention
Stroke
Time Factors
Treatment Outcome
Triglycerides

authors with profiles

Larry Goldstein